Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | BMY | AMGN | GILD | VRTX |
| Company | Dicerna Pharmaceutic | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 38.21 | 48.21 | 264.63 | 66.25 | 394.72 |
| High | 38.24 | 49.05 | 269.38 | 66.83 | 396.98 |
| Low | 38.21 | 48.12 | 260.68 | 66.16 | 391.25 |
| Last | 38.22 | 48.93 | 268.93 | 66.76 | 394.28 |
| Change | +0.22 | +0.63 | +6.18 | +0.60 | +0.80 |
| % Change | +0.58% | +1.30% | +2.35% | +0.91% | +0.20% |
| Volume | 5,568,900 | 10,303,895 | 3,380,000 | 10,656,899 | 1,342,000 |
| 20-Day Average Volume | 3,647,665 | 11,303,495 | 2,246,420 | 6,455,915 | 931,820 |
| Previous Close | 38.00 | 48.30 | 262.75 | 66.16 | 393.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 50.85 | 272.56 | 69.90 | 405.52 |
| 20-Day Raw Stochastic | 90.72% | 19.17% | 29.59% | 10.79% | 10.74% |
| 20-Day Relative Strength | 80.40% | 41.16% | 43.95% | 31.30% | 37.76% |
| Weighted Alpha | +35.17 | -28.90 | +7.67 | -24.32 | +15.95 |
| Today's Opinion | 88% Buy | 72% Sell | 56% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 72% Buy | 72% Sell | 56% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 24% Buy | 24% Sell | 8% Sell | 72% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | +1.35% since 04/12/24 | +0.62% since 04/12/24 | -1.92% since 04/12/24 | -0.57% since 04/12/24 |
| Low | 37.81 on 12/21/21 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 38.24 on 12/27/21 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 402.49 on 04/15/24 |
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | -5.54% since 03/19/24 | -1.03% since 03/19/24 | -9.06% since 03/19/24 | -5.04% since 03/19/24 |
| Low | 37.78 on 12/10/21 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 38.26 on 12/03/21 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | -2.35% since 01/19/24 | -12.63% since 01/19/24 | -23.52% since 01/19/24 | -9.37% since 01/19/24 |
| Low | 19.06 on 10/06/21 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 38.26 on 12/03/21 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | -13.37% since 10/19/23 | -4.16% since 10/19/23 | -14.89% since 10/19/23 | +8.08% since 10/19/23 |
| Low | 19.06 on 10/06/21 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 40.14 on 07/20/21 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 97,892,464 | 140,812,720 | 82,374,304 | 101,698,464 |
| Shares Outstanding, K | 78,129 | 2,026,759 | 535,919 | 1,245,077 | 258,459 |
| Annual Sales | 164,310,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -112,750,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 62,950,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -17,070,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 0.80 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 11/09/21 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 29.25 |